Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.95 USD | +3.34% | +6.91% | -19.38% |
May. 06 | Transcript : ATI Physical Therapy, Inc., Q1 2024 Earnings Call, May 06, 2024 | |
May. 06 | Earnings Flash (ATIP) ATI PHYSICAL THERAPY Posts Q1 Revenue $181.5M, vs. Street Est of $173.7M | MT |
Valuation
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Capitalization 1 | 462.7 | 668.7 | 63.21 | 25.84 | 21.76 | - |
Enterprise Value (EV) 1 | 462.7 | 668.7 | 511.7 | 25.84 | 21.76 | 21.76 |
P/E ratio | -1,073 x | -0.72 x | -0.12 x | -0.19 x | -0.4 x | -0.43 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.78 x | 1.07 x | 0.1 x | 0.04 x | 0.03 x | 0.03 x |
EV / Revenue | 0.78 x | 1.07 x | 0.1 x | 0.04 x | 0.03 x | 0.03 x |
EV / EBITDA | - | 16.8 x | 9.42 x | 0.71 x | 0.5 x | 0.4 x |
EV / FCF | - | - | -0.67 x | -0.87 x | -0.59 x | -1.1 x |
FCF Yield | - | - | -148% | -115% | -169% | -90.8% |
Price to Book | - | - | 1.36 x | - | - | - |
Nbr of stocks (in thousands) | 863 | 3,945 | 4,145 | 4,209 | 4,396 | - |
Reference price 2 | 536.5 | 169.5 | 15.25 | 6.140 | 4.950 | 4.950 |
Announcement Date | 3/12/21 | 2/25/22 | 3/16/23 | 2/26/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Net sales 1 | 592.3 | 627.9 | 635.7 | 699 | 750.7 | 761.6 |
EBITDA 1 | - | 39.77 | 6.712 | 36.23 | 43.85 | 54.44 |
EBIT 1 | - | -980 | -539.7 | -27.52 | -0.7 | 13.73 |
Operating Margin | - | -156.09% | -84.91% | -3.94% | -0.09% | 1.8% |
Earnings before Tax (EBT) 1 | - | -853 | -541.6 | -63.51 | -34.51 | -39.55 |
Net income 1 | - | -782 | -493 | -132 | -38.28 | -41.92 |
Net margin | - | -124.55% | -77.56% | -18.88% | -5.1% | -5.5% |
EPS 2 | -0.5000 | -234.5 | -125.5 | -31.93 | -12.37 | -11.61 |
Free Cash Flow 1 | - | - | -93.66 | -29.69 | -36.69 | -19.75 |
FCF margin | - | - | -14.73% | -4.25% | -4.89% | -2.59% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 3/12/21 | 2/25/22 | 3/16/23 | 2/26/24 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 155.8 | 153.8 | 163.3 | 156.8 | 161.8 | 166.9 | 172.3 | 177.5 | 182.3 | 181.5 | 190 | 187.4 | 191.8 | 177.5 | 183.8 |
EBITDA 1 | 1.643 | -4.695 | 5.436 | -0.392 | 6.363 | 4.79 | 9.338 | 9.429 | 12.68 | 6.463 | 14.3 | 10.03 | 13.05 | 11.9 | 16.5 |
EBIT 1 | -12.11 | -176.1 | -139.9 | -119.7 | -104.1 | -11.37 | -12.36 | -0.764 | -3.024 | -4.778 | 1.3 | -1.9 | 4.064 | 0.2 | 4.3 |
Operating Margin | -7.78% | -114.47% | -85.64% | -76.32% | -64.38% | -6.81% | -7.17% | -0.43% | -1.66% | -2.63% | 0.68% | -1.01% | 2.12% | 0.11% | 2.34% |
Earnings before Tax (EBT) 1 | -3.691 | -161.5 | -148.8 | -123.9 | -107.4 | -25.15 | -21.66 | -14.48 | -2.222 | -13.66 | -6.718 | -10.5 | -7.271 | -14.8 | -10.7 |
Net income 1 | 8.736 | -137.8 | -135.5 | -116.7 | -102.4 | -26.27 | -22.7 | -18.34 | -8.944 | -14.65 | -7.734 | -11.1 | -8.439 | -14.9 | -10.8 |
Net margin | 5.61% | -89.55% | -83.01% | -74.43% | -63.31% | -15.74% | -13.17% | -10.34% | -4.91% | -8.07% | -4.07% | -5.92% | -4.4% | -8.39% | -5.88% |
EPS 2 | 19.00 | -35.00 | -33.24 | -30.00 | -26.50 | -7.500 | -5.508 | -4.420 | -2.150 | -3.505 | -2.630 | -3.440 | -2.800 | -3.580 | -2.590 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 2/25/22 | 5/9/22 | 8/8/22 | 11/7/22 | 3/16/23 | 5/8/23 | 8/7/23 | 11/6/23 | 2/26/24 | 5/6/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Net Debt | - | - | 448 | - | - | - |
Net Cash position | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | 66.81 x | - | - | - |
Free Cash Flow 1 | - | - | -93.7 | -29.7 | -36.7 | -19.7 |
ROE (net income / shareholders' equity) | - | -7.63% | -180% | - | - | - |
ROA (Net income/ Total Assets) | - | - | -37.3% | - | - | - |
Assets 1 | - | - | 1,321 | - | - | - |
Book Value Per Share | - | - | 11.20 | - | - | - |
Cash Flow per Share | - | - | -16.70 | - | - | - |
Capex 1 | - | - | 28.1 | 17.3 | 14.9 | 15 |
Capex / Sales | - | - | 4.43% | 2.48% | 1.99% | 1.97% |
Announcement Date | 3/12/21 | 2/25/22 | 3/16/23 | 2/26/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.38% | 21.76M | |
+20.68% | 85.55B | |
-29.31% | 70.07B | |
+9.65% | 29.06B | |
-8.63% | 17.51B | |
+2.14% | 17.39B | |
+0.39% | 15.38B | |
+6.47% | 13.4B | |
+68.23% | 12.42B | |
+6.43% | 12.77B |
- Stock Market
- Equities
- ATIP Stock
- Financials ATI Physical Therapy, Inc.